Journal of Korean Medical Science · Nov 9, 2026
Elevated Risk of Bladder Cancer Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease in Elderly Korean Men: A Nationwide Cohort Study
By Lee J, Kang ES, Park HS et al.
BACKGROUND: Steatotic liver disease (SLD) is one of the major metabolic disorders associated with various extrahepatic malignancies. Although growing evidence suggests a link between SLD and bladder cancer, the precise nature of this relationship remains unclear. The goal of our study was to explore the relationship between SLD subtypes and the risk of bladder cancer in elderly Korean men. METHODS: This nationwide population-based cohort study utilized data from South Korean men aged 65 years and older, collected from 2009 to 2010. The subdistribution hazard ratios (SHRs) and 95% confidence intervals (CIs) were evaluated using the Fine and Gray regression model, with all-cause mortality considered as a competing event. Inverse probability of treatment weighting (IPTW) was applied to the SLD and non-SLD groups to create a pseudo-population, enabling a more unbiased evaluation. Overall, the bladder cancer incidence was compared across the SLD and non-SLD groups. RESULTS: Among 89,903 Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) participants, 1,048 bladder cancer cases were identified, compared to 935 in 84,111 non-SLD participants after IPTW (1.17% vs. 1.11%). In MASLD with increased alcohol intake (MetALD) group, 456 cases were found among 61,709 individuals, versus 578 in 51,765 non-SLD participants (0.74% vs. 1.12%). In this cohort, MASLD revealed an association with a greater risk of bladder cancer (aHR, 1.11; 95% CI, 1.01-1.21; P = 0.027), whereas MetALD showed a decreased risk (aHR, 0.67; 95% CI, 0.59-0.76; P < 0.001). The risk was more pronounced in individuals aged < 75 years and in those who engaged in moderate-to-vigorous physical activity. CONCLUSION: MASLD was associated with an increased risk of bladder cancer, and this association remained significant among never smokers after excluding cases within 3 years.
doi.org/10.3346/jkms.2026.41.e274Open accessPubMed 43009147Populations